LGR4 antibody

Ref. 3D-10R-4633

Produktinformation

• Name: LGR4 antibody
• Marke: Biosynth
• Beschreibung: The LGR4 antibody is a cytotoxic agent that belongs to the family of Life Sciences antibodies. It has shown anti-VEGF (vascular endothelial growth factor) activity and can inhibit the function of tyrosinase, an enzyme involved in melanin production. Additionally, this antibody has neutralizing effects against CD33, a protein expressed on the surface of certain cancer cells. The LGR4 antibody acts as a family kinase inhibitor, blocking the activity of specific kinases involved in cell signaling pathways. It can be used in combination with other antibodies, such as trastuzumab, for targeted cancer therapy. Furthermore, this monoclonal antibody has been shown to have hormone peptide-like properties and can modulate endothelial growth. Its mechanism of action involves binding to specific targets on cells and interfering with their function. The LGR4 antibody may also exhibit anti-inflammatory effects by inhibiting TNF-α (tumor necrosis factor-alpha) production.